Literature DB >> 24461908

Incidence and carrier frequency of Sandhoff disease in Saskatchewan determined using a novel substrate with detection by tandem mass spectrometry and molecular genetic analysis.

Braden Fitterer1, Patricia Hall2, Nick Antonishyn3, Rajagopal Desikan4, Michael Gelb5, Denis Lehotay6.   

Abstract

Sandhoff disease is a rare progressive neurodegenerative genetic disorder with a high incidence among certain isolated communities and ethnic groups around the world. Previous reports have shown a high occurrence of Sandhoff disease in northern Saskatchewan. Newborn screening cards from northern Saskatchewan were retrospectively screened in order to investigate the incidence and determine the carrier frequency of Sandhoff disease in these communities. PCR-based screening was conducted for the c.115delG (p.(Val39fs)) variant in the HEXB gene that was previously found in 4 Sandhoff disease patients from this area. The carrier frequency for this allele was estimated to be ~1:27. MS/MS-based screening of hexosaminidase activity along with genetic sequencing allowed for the identification of additional variants based on low total hexosaminidase activity and high % hexosaminidase A activity relative to c.115delG carriers. In total 4 pathogenic variants were discovered in the population (c.115delG, c.619A>G, c.1601G>T, and c.1652G>A) of which two are previously unreported (c.1601G>T and c.1652G>A). The combined carrier frequency of these alleles in the study area was estimated at ~1:15. Based on the number of cases of Sandhoff disease from this area we estimate the incidence to be ~1:390 corresponding to a child being born with the disease every 1-2 years on average. The results from our study were then compared with variants in the HEXB gene from the genomes available from the 1000 Genomes project. A total of 19 HEXB variants were found in the 1092 genomes of which 5 are suspected of having a deleterious effect on hexosaminidase activity. The estimated carrier frequency of Sandhoff disease in Saskatchewan at 1:15 is more than 3 times higher than the carrier frequency in the global sample provided by the 1000 Genomes project at 1:57.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  GM2; Gangliosidosis; HEXB; Hexosaminidase; Sandhoff; Tay–Sachs

Mesh:

Substances:

Year:  2014        PMID: 24461908      PMCID: PMC4346577          DOI: 10.1016/j.ymgme.2014.01.002

Source DB:  PubMed          Journal:  Mol Genet Metab        ISSN: 1096-7192            Impact factor:   4.797


  31 in total

Review 1.  Pre-mRNA splicing and human disease.

Authors:  Nuno André Faustino; Thomas A Cooper
Journal:  Genes Dev       Date:  2003-02-15       Impact factor: 11.361

2.  Characterization of Hex S, the major residual beta hexosaminidase activity in type O Gm2 gangliosidosis (Sandhoff-Jatzkewitz disease).

Authors:  J U Ikonne; M C Rattazzi; R J Desnick
Journal:  Am J Hum Genet       Date:  1975-09       Impact factor: 11.025

3.  Diagnosis and high incidence of hyperornithinemia-hyperammonemia-homocitrullinemia (HHH) syndrome in northern Saskatchewan.

Authors:  AbdulRazaq A H Sokoro; Joyce Lepage; Nick Antonishyn; Ryan McDonald; Cheryl Rockman-Greenberg; James Irvine; Denis C Lehotay
Journal:  J Inherit Metab Dis       Date:  2010-06-24       Impact factor: 4.982

Review 4.  Biochemical consequences of mutations causing the GM2 gangliosidoses.

Authors:  D J Mahuran
Journal:  Biochim Biophys Acta       Date:  1999-10-08

5.  Tay-sachs disease. Detection of heterozygotes and homozygotes by serum hexosaminidase assay.

Authors:  J S O'Brien; S Okada; A Chen; D L Fillerup
Journal:  N Engl J Med       Date:  1970-07-02       Impact factor: 91.245

6.  The X-ray crystal structure of human beta-hexosaminidase B provides new insights into Sandhoff disease.

Authors:  Timm Maier; Norbert Strater; Christina G Schuette; Ralf Klingenstein; Konrad Sandhoff; Wolfram Saenger
Journal:  J Mol Biol       Date:  2003-05-02       Impact factor: 5.469

7.  Crystal structure of human beta-hexosaminidase B: understanding the molecular basis of Sandhoff and Tay-Sachs disease.

Authors:  Brian L Mark; Don J Mahuran; Maia M Cherney; Dalian Zhao; Spencer Knapp; Michael N G James
Journal:  J Mol Biol       Date:  2003-04-11       Impact factor: 5.469

8.  Hexosaminidase isozyme in type O Gm2 gangliosidosis (Sandhoff-Jatzkewitz disease).

Authors:  E Beutler; W Kuhl; D Comings
Journal:  Am J Hum Genet       Date:  1975-09       Impact factor: 11.025

9.  Tay-Sachs disease: generalized absence of a beta-D-N-acetylhexosaminidase component.

Authors:  S Okada; J S O'Brien
Journal:  Science       Date:  1969-08-15       Impact factor: 47.728

10.  Genetic variants of Tay-Sachs disease: Tay-Sachs disease and Sandhoff's disease in French Canadians, juvenile Tay-Sachs disease in Lebanese Canadians, and a Tay-Sachs screening program in the French-Canadian population.

Authors:  E Andermann; C R Scriver; L S Wolfe; L Dansky; F Andermann
Journal:  Prog Clin Biol Res       Date:  1977
View more
  6 in total

1.  Clinical,biochemical and molecular analysis of five Chinese patients with Sandhoff disease.

Authors:  Wen Zhang; Huasong Zeng; Yonglan Huang; Ting Xie; Jipeng Zheng; Xiaoyuan Zhao; Huiying Sheng; Hongsheng Liu; Li Liu
Journal:  Metab Brain Dis       Date:  2016-03-28       Impact factor: 3.584

2.  Prevalence estimation for monogenic autosomal recessive diseases using population-based genetic data.

Authors:  Steven J Schrodi; Andrea DeBarber; Max He; Zhan Ye; Peggy Peissig; Jeffrey J Van Wormer; Robert Haws; Murray H Brilliant; Robert D Steiner
Journal:  Hum Genet       Date:  2015-04-19       Impact factor: 4.132

Review 3.  Newborn screening for lysosomal storage diseases.

Authors:  Michael H Gelb; C Ronald Scott; Frantisek Turecek
Journal:  Clin Chem       Date:  2014-12-04       Impact factor: 8.327

4.  Lifetime risk of autosomal recessive mitochondrial disorders calculated from genetic databases.

Authors:  Jing Tan; Matias Wagner; Sarah L Stenton; Tim M Strom; Saskia B Wortmann; Holger Prokisch; Thomas Meitinger; Konrad Oexle; Thomas Klopstock
Journal:  EBioMedicine       Date:  2020-04-16       Impact factor: 8.143

5.  Infantile onset Sandhoff disease: clinical manifestation and a novel common mutation in Thai patients.

Authors:  Thipwimol Tim-Aroon; Khunton Wichajarn; Kamornwan Katanyuwong; Pranoot Tanpaiboon; Nithiwat Vatanavicharn; Kullasate Sakpichaisakul; Arthaporn Kongkrapan; Jakris Eu-Ahsunthornwattana; Supranee Thongpradit; Kanya Moolsuwan; Nusara Satproedprai; Surakameth Mahasirimongkol; Tassanee Lerksuthirat; Bhoom Suktitipat; Natini Jinawath; Duangrurdee Wattanasirichaigoon
Journal:  BMC Pediatr       Date:  2021-01-07       Impact factor: 2.125

6.  Lysosomal gene Hexb displays haploinsufficiency in a knock-in mouse model of Alzheimer's disease.

Authors:  Lauren S Whyte; Célia Fourrier; Sofia Hassiotis; Adeline A Lau; Paul J Trim; Leanne K Hein; Kathryn J Hattersley; Julien Bensalem; John J Hopwood; Kim M Hemsley; Timothy J Sargeant
Journal:  IBRO Neurosci Rep       Date:  2022-01-20
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.